Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes
Clinical trial NCT00447382 · COMPLETED
Trial details
- NCT number
- NCT00447382
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-07-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.